The Korea Food and Drug Administration said on June 28 it has given a green light to Priligy (dapoxetine) for the treatment of premature ejaculation (PE) in men, according to Janssen Korea.
Dapoxetine, an selective serotonin re-uptake inhibitor (SSRI) designed to treat PE, not approved as an antidepressant.
Premature ejaculation is the most common sexual disorder among men, with a prevale...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.